Biography
Biography: Sadhna Nandwana
Abstract
Review the issue of NSF in renal failure patients with usage of gadolinium based contrast agents (GBCAs) and provide an update of current literature regarding risks of NSF with certain GBCAs. Also, This presentation will discuss the current national/international recommendations and explore eliminating screening of at-risk patients. Presentation will include the timeline of NSF discovery, types of GBCAs, known cases of NSF and current research on commonly used GBCAs in renal impaired patients. Recent landmark papers regarding risk of NSF with gadobenate dimeglumine will be specifically discussed. The controversy of renal failure patients receiving MRIs with contrast will be explored and the risks and benefits will be discussed.